Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tesch

Showing results (221-230 of 282) with videos related to

Pageof 29
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study GroupV Diehl, M Sieber, U Rüffer, et al.
Cytokines and Molecular Therapy|September 1, 1996
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell linesA Klimka, S Barth, S Drillich, et al.
Journal of the American Society of Nephrology : JASN|March 26, 1998
Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivoG H Tesch, D J Nikolic-Paterson, C N Metz, et al.
Annals of Hematology|October 20, 1999
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AMLH T Steinmetz, A Schulz, P Staib, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1997
Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidneyG H Tesch, N Yang, H Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSGU Rueffer, M Sieber, A Josting, et al.
Transplantation|June 9, 2017
Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized RecipientsSharmila Ramessur Chandran, Yingjie Han, Greg H Tesch, et al.
Kidney International|March 13, 2003
Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin IIEdwina K Rice, Gregory H Tesch, Zemin Cao, et al.
Kidney International|October 24, 2000
CD44-mediated neutrophil apoptosis in the ratK Takazoe, G H Tesch, P A Hill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivityY S Kim, W Maslinski, X X Zheng, et al.
Pageof 29

Showing results (221-230 of 282) with videos related to

Sort By:
Pageof 29
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study GroupV Diehl, M Sieber, U Rüffer, et al.
Cytokines and Molecular Therapy|September 1, 1996
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell linesA Klimka, S Barth, S Drillich, et al.
Journal of the American Society of Nephrology : JASN|March 26, 1998
Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivoG H Tesch, D J Nikolic-Paterson, C N Metz, et al.
Annals of Hematology|October 20, 1999
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AMLH T Steinmetz, A Schulz, P Staib, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1997
Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidneyG H Tesch, N Yang, H Yu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSGU Rueffer, M Sieber, A Josting, et al.
Transplantation|June 9, 2017
Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized RecipientsSharmila Ramessur Chandran, Yingjie Han, Greg H Tesch, et al.
Kidney International|March 13, 2003
Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin IIEdwina K Rice, Gregory H Tesch, Zemin Cao, et al.
Kidney International|October 24, 2000
CD44-mediated neutrophil apoptosis in the ratK Takazoe, G H Tesch, P A Hill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 1998
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivityY S Kim, W Maslinski, X X Zheng, et al.
Pageof 29